Gastric adenocarcinoma

Abstract
In spite of the declining incidence of gastric adenocarcinoma observed during the last 30 years in the U.S., this disease continues to carry a very bleak prognosis. Even with the best forms of treatment, the overall survival remains approximately 7%.